Karine Barral - Concepedia

Concepedia

Author

Karine Barral

Centre National de la Recherche Scientifique ORCID

Also Known As

Barral, Karine, K Barral, K. Barral, Karine Barral

35

Publications

1.6K

Citations

14

H-Index

25

Concepts

All Affiliations

Centre National de la Recherche Scientifique Aix-Marseille Université Inserm Institut de Recherche pour le Développement Architecture et Fonction des Macromolécules Biologiques

KB

About

Karine Barral is an author at Centre National de la Recherche Scientifique specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	431
2	Biochemistry	3	3	201
3	Natural Sciences	2	2	59
4	Biomolecular Engineering	2	2	106
5	Engineering	1	1	397

Karine Barral

×

19

Publications

1.6K

Citations

14

H-Index

	Year	Citations
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication Franck Touret, Magali Gilles, Karine Barral, Scientific Reports	2020	425
Efficient Conversion of Aromatic Amines into Azides: A One-Pot Synthesis of Triazole Linkages Karine Barral, Adam D. Moorhouse, John E. Moses Organic Letters EngineeringHeterocyclicTriazole LinkagesOne-pot SynthesisAromatic Amines	2007	397
Zika Virus Methyltransferase: Structure and Functions for Drug Design Perspectives Bruno Coutard, Karine Barral, Julie Lichière, Journal of Virology	2016	139
Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design Fatiha Benmansour, Iuni Margaret Laura Trist, Bruno Coutard, European Journal of Medicinal Chemistry BiochemistryMedicineFragment-based Drug DesignAntiviral Drug DevelopmentAntiviral Therapy	2016	92
Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery Bruno Coutard, Étienne Decroly, Changqing Li, Antiviral Research Fragment-based Drug DiscoveryDrug TargetBiochemistryMedicineBioanalysis	2014	75
Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase Fatiha Benmansour, Cécilia Eydoux, Gilles Quérat, European Journal of Medicinal Chemistry Medicinal ChemistryMedicineDengue Virus InhibitorsAntiviral Drug DevelopmentAntiviral Therapy	2015	72
<i>In vitro</i> screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication Franck Touret, Magali Gilles, Karine Barral, Pre-clinical PharmacologyAntimicrobial Drug DiscoveryChloroquine DerivativesViral DiagnosticsPrestwick Chemical Library®	2020	63
Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo Raphaël Leblanc, Rudra Kashyap, Karine Barral, Journal of Extracellular Vesicles	2020	54
Synthesis, in Vitro Antiviral Evaluation, and Stability Studies of Novel α-Borano-Nucleotide Analogues of 9-[2-(Phosphonomethoxy)ethyl]adenine and (<i>R</i>)-9-[2-(Phosphonomethoxy)propyl]adenine Karine Barral, Stéphane Priet, Joséphine Sire, Journal of Medicinal Chemistry	2006	52
Development of specific dengue virus 2′-O- and N7-methyltransferase assays for antiviral drug screening Karine Barral, Corinne Sallamand, Christine Petzold, Antiviral Research Antiviral Drug ScreeningSpecific Dengue VirusN7-methyltransferase AssaysMedicinePharmacology	2013	46

Page 1